A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

NCT03019809 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Wiskott-Aldrich Syndrome
Hematopoietic Stem Cell Transplantation
Graft Failure

Interventions

BIOLOGICAL: G-CSF for Conditioning before HSCT.
BIOLOGICAL: Plerixafor for Conditioning before HSCT.

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology